Patent details

EP1492513 Title: HFA-SUSPENSION FORMULATIONS CONTAINING AN ANTICHOLINERGIC

Basic Information

Publication number:
EP1492513
PCT Application Number:
PCT/EP/2003/002898
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP037451937
PCT Publication Number:
WO/2003/082252
First applicant's nationality:
Translation Language:
EPO Publication Language:
German
English Title of Invention:
HFA-SUSPENSION FORMULATIONS CONTAINING AN ANTICHOLINERGIC
French Title of Invention:
FORMULATIONS DE SUSPENSIONS CONTENANT UN GAZ PROPULSEUR HFA ET UN ANTICHOLINERGIQUE
German Title of Invention:
HFA-SUSPENSIONSFORMULIERUNGEN ENTHALTEND EIN ANTICHOLINERGIKUM
SPC Number:

Dates

Filing date:
20/03/2003
Grant date:
20/09/2006
EP Publication Date:
20/09/2006
PCT Publication Date:
09/10/2003
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/01/2005
EP B1 Publication Date:
20/09/2006
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
20/03/2022
Expiration date:
20/03/2023
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/03/2003
 
 

Name:
Boehringer Ingelheim Pharma GmbH & Co.KG
Address:
Binger Strasse 173, 55216 Ingelheim am Rhein, Germany (DE)

Inventor

Name:
SCHMELZER Christel
Address:
Germany (DE)

Priority

Priority Number:
10214263
Priority Date:
28/03/2002
Priority Country:
Germany (DE)

Classification

Main IPC Class:
A61K 9/72;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
19/03/2021
Last Annual Fee Paid Number:
19
Last Annual Fee Paid Amount:
281 Euro
Payer:
DENNEMEYER & CO
Filing date Document type Number of pages